Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;1(2):13.
doi: 10.3978/j.issn.2305-5839.2012.10.02.

The fetal liver as cell source for the regenerative medicine of liver and pancreas

Affiliations
Review

The fetal liver as cell source for the regenerative medicine of liver and pancreas

Rossella Semeraro et al. Ann Transl Med. 2013 Jul.

Abstract

Patients affected by liver diseases and diabetes mellitus are in need for sources of new cells to enable a better transition into clinic programs of cell therapy and regenerative medicine. In this setting, fetal liver is becoming the most promising and available source of cells. Fetal liver displays unique characteristics given the possibility to isolate cell populations with a wide spectrum of endodermal differentiation and, the co-existence of endodermal and mesenchymal-derived cells. Thus, the fetal liver is a unique and highly available cell source contemporarily candidate for the regenerative medicine of both liver and pancreas. The purpose of this review is to revise the recent literature on the different stem cells populations isolable from fetal liver and candidate to cell therapy of liver diseases and diabetes and to discuss advantages and limitation with respect to other cell sources.

Keywords: Fetal liver; biliary tree stem/progenitor cells; cell therapy; diabetes mellitus; hematopoietic stem cells; hepatic stem/progenitor cells; hepatoblasts; liver cirrhosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Location and phenotype of different stem cells populations isolatable from fetal liver at 18th-22nd gestational age. BTSCs, biliary tree stem/progenitor cells, HpSCs, hepatic stem/progenitor cells, HBs hepatoblasts. ‡Markers found on the cell surface (all others listed are intracellular). (-) Negative. Abbreviations: AFP, α-fetoprotein; ALB, albumin; CD, common determinant; CD133, prominin; CK, cytokeratin; CXCR4, CXC-chemokine receptor 4; EpCAM, epithelial cell adhesion molecule; FOXa2, forkhead box a2; HES1, a member of the basic helix-loop-helix family of transcription factors and a transcriptional repressor of genes requiring an HLH protein for their transcription; HNF, hepatocyte nuclear factor; ICAM1, intercellular adhesion molecule 1, IHH, Indian Hedgehog; LGR5, Leucine-rich repeat-containing G-protein coupled receptor 5 that binds to R-Spondin; NANOG, Nanog homeobox; NCAM, neural cell adhesion molecule; NGN3, neurogenin 3; PAX genes, trancription factors regulating development; PDX1, Pancreatic and duodenal homeobox 1; PROX1, Prospero homeobox protein 1; PTC1, patched 1; PTF1, a trimeric transcription factor essential for pancreas development; P450 cytochrome P450; SHH, Sonic Hedgehog; SOX, Sry-related HMG box; VEGFR2, vascular endothelial growth factor 2.

References

    1. Cardinale V, Wang Y, Carpino G, et al. The biliary tree--a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 2012;9:231-40. - PubMed
    1. Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007;204:1973-87. - PMC - PubMed
    1. Turner R, Lozoya O, Wang Y, et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011;53:1035-45. - PMC - PubMed
    1. Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology 2011;54:2159-72. - PubMed
    1. Forbes SJ, Newsome PN. New horizons for stem cell therapy in liver disease. J Hepatol 2012;56:496-9. - PubMed